Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Study protocol

Evaluation of a cancer patient navigation program (“Onkolotse”) in terms of hospitalization rates, resource use and healthcare costs: rationale and design of a randomized, controlled study

Authors: Ralf Porzig, Sina Neugebauer, Thomas Heckmann, Daniela Adolf, Peter Kaskel, Ursula G. Froster

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

Concepts for the nursing and care of cancer patients through a “navigation service” have attracted much interest. However, there is still room for improvement in terms of their funding and coverage. The Saxon Cancer Society designed a prospective, randomized, multicenter, longitudinal study with a view to determining the positive effects of a cancer patient navigator program. The objective of this ongoing study is to evaluate the impact of the cancer patient navigation program on cancer patients and cost bearers in Germany.

Methods

The study population in this evaluation comprises cancer patients with gastric carcinoma, pancreatic carcinoma, colorectal cancer, melanoma or gynecological cancer who have been hospitalized at least once at one of the study centers as well as their relatives, outpatient and inpatient physicians, and cancer nurses. It is planned to randomize 340 cancer patients (stomach, colonic/rectal cancer, gynecological cancer, melanoma) at five centers to an intervention group (care by patient navigators based on standardized operating procedures) or a control group in a one-to-one ratio. The primary target parameter is the number of hospitalizations within the 12-month intervention period. The participants are asked to complete various questionnaires on patient-related outcomes at baseline and at 3 and 12 months (SF 36, HADS, PAM 13, and others). Data on drug therapy, utilization of health services, and medical expenses will also be analyzed.

Discussion

For the first time, the study will provide data on the effectiveness of a patient support program in cancer care in Germany from a randomized trial with a high level of evidence.

Trial registration

The study has been registered under DRKS00013199 in the German Clinical Trials Register.
Literature
1.
2.
Freeman HP, Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005;14(4):655–69. vCrossRefPubMed
3.
4.
Freeman HP. Patient navigation: a community-centered approach to reducing cancer mortality. J Cancer Educ. 2006;21(1 Suppl):11–4.CrossRef
5.
Freund KM, Battaglia TA, Calhoun E, Dudley DJ, Fiscella K, Paskett E, et al. National Cancer Institute patient navigation research program: methods, protocol, and measures. Cancer. 2008;113(12):3391–9.CrossRefPubMedPubMedCentral
6.
Thygesen MK, Pedersen BD, Kragstrup J, Wagner L, Mogensen O. Benefits and challenges perceived by patients with cancer when offered a nurse navigator. Int J Integr Care. 2011;11:e130.CrossRefPubMedPubMedCentral
7.
Clark JA, Parker VA, Battaglia TA, Freund KM. Patterns of task and network actions performed by navigators to facilitate cancer care. Health Care Manag Rev. 2014;39(2):90–101.CrossRef
8.
Fiscella K, Whitley E, Hendren S, Raich P, Humiston S, Winters P, et al. Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomark Prev. 2012;21(10):1673–81.CrossRef
9.
Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, et al. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014;32(1):12–8.CrossRefPubMed
10.
Skrutkowski M, Saucier A, Eades M, Swidzinski M, Ritchie J, Marchionni C, et al. Impact of a pivot nurse in oncology on patients with lung or breast cancer: symptom distress, fatigue, quality of life, and use of healthcare resources. Oncol Nurs Forum. 2008;35(6):948–54.CrossRefPubMed
11.
12.
Porzig R, Heckmann T, Froster UG. Lotsensysteme und ihr Beitrag zur Chancengleichheit im Gesundheitswesen. Forum. 2017;32(4):324–9.CrossRef
13.
14.
Herrmann C. International experiences with the hospital anxiety and depression scale – a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17–41.CrossRefPubMed
15.
Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats H, Ruger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med. 1998;60(5):570–7.CrossRefPubMed
16.
Herrmann C, Buss U. Vorstellung und Validierung einer deutschen Version der, Hospital Anxiety and Depression Scale HAD-Skala. Diagnostica. 1994;40(2):143–54.
17.
18.
19.
Subramanian SV, Huijts T, Avendano M. Self-reported health assessments in the 2002 world health survey: how do they correlate with education? Bull World Health Organ. 2010;88(2):131–8.CrossRefPubMed
20.
Lorig K, Stewart A, Ritter P, González V, Laurent D, Lynch J. Outcome Measures for Health Education and other Health Care Interventions. Thousand Oaks CA: Sage Publications; 1996. p. 25.
21.
22.
23.
Tiller D, Herzog B, Kluttig A, Haerting J. Health literacy in an urban elderly east-German population - results from the population-based CARLA study. BMC Public Health. 2015;15:883.CrossRefPubMedPubMedCentral
24.
Rademakers J, Maindal HT, Steinsbekk A, Gensichen J, Brenk-Franz K, Hendriks M. Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form patient activation measure (PAM-13). BMC Health Serv Res. 2016;16(1):570.CrossRefPubMedPubMedCentral
25.
Scholl I, Kriston L, Härter M. PEF-FB-9. Fragebogen zur Partizipativen Entscheidungsfindung (revidierte 9-Item Fassung). Klinische Diagnostik und Evaluation, 4. Auflage, Seiten 46ff.
Metadata
Title
Evaluation of a cancer patient navigation program (“Onkolotse”) in terms of hospitalization rates, resource use and healthcare costs: rationale and design of a randomized, controlled study
Authors
Ralf Porzig
Sina Neugebauer
Thomas Heckmann
Daniela Adolf
Peter Kaskel
Ursula G. Froster
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3226-3

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue

Research article

Effects of a multifaceted intervention QI program to improve ICU performance

Research article

Curriculum and training needs of mid-level health workers in Africa: a situational review from Kenya, Nigeria, South Africa and Uganda

Research article

Use of an electronic medical record reminder improves HIV screening

Research article

Temporary exclusion of ill children from childcare centres in Switzerland: practice, problems and potential solutions

Research article

Evaluating organizational change in health care: the patient-centered hospital model

Research article

24-hour access outpatient clinic for patients with exacerbation of chronic disease: a before-after cohort study of differences in acute healthcare utilisation